Across TCGA pan-cancer cohorts, RPL27AP3 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL27AP3’s most consistent transcriptional readouts.
The strongest signal is observed in thyroid carcinoma (THCA), where RPL27AP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL27AP3 is over-expressed in tumor.
THCA and PRAD are the cancer types where RPL27AP3 tumor–normal differential expression is most reproducible.